EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Molecular mechanisms of microRNA-92b during tumor progression and metastasis

Amirhosein Maharati, Meysam Moghbeli

Cancer Treatment and Research Communications · 2026 · 49 · 101513

DOI: 10.1016/j.ctarc.2026.101513 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Treatment and Research Communications, 2026. Verfasst von Amirhosein Maharati und 1 weiteren Autor:innen. Beteiligte Einrichtung: Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. Die Arbeit nennt 191 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

MicroRNAs (miRNAs) have emerged as crucial regulators of gene expression in cancer, where they can function as either oncogenes or tumor suppressors by modulating molecular pathways controlling cell proliferation, apoptosis, invasion, and metastasis. Among these, miR-92b has garnered increasing attention due to its context‑dependent roles across different malignancies. Depending on the tumor type, miR-92b exhibits dual functionality as an oncogene or tumor suppressor. Clinically, aberrant expression of miR-92b has been correlated with patient prognosis, chemo resistance, and metastatic potential, positioning it as a promising non-invasive biomarker for early diagnosis, staging, and therapeutic response monitoring. Furthermore, preclinical strategies aimed at restoring or inhibiting miR-92b have demonstrated potential for targeted intervention, though challenges remain in achieving cell-specific delivery and avoiding off-target effects. This review consolidates current evidence on the mechanistic, diagnostic, and therapeutic facets of miR-92b, underscoring its relevance as a multifaceted player in cancer biology and a candidate for future clinical translation.

Schlagwörter

Stichwörter der Autor:innen

CancerDiagnosisMarkermicroRNA-92b

Autor:innen und Institutionen

  • Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: moghbelim@mums.ac.ir.

Zitieren

APA

Maharati, A., & Moghbeli, M. (2026). Molecular mechanisms of microRNA-92b during tumor progression and metastasis. Cancer Treatment and Research Communications, 49, 101513. https://doi.org/10.1016/j.ctarc.2026.101513

Vancouver

Maharati A, Moghbeli M. Molecular mechanisms of microRNA-92b during tumor progression and metastasis. Cancer Treatment and Research Communications. 2026;49:101513. doi:10.1016/j.ctarc.2026.101513

BibTeX
@article{Maharati2026,
  author = {Maharati, Amirhosein and Moghbeli, Meysam},
  title = {Molecular mechanisms of microRNA-92b during tumor progression and metastasis},
  journal = {Cancer Treatment and Research Communications},
  year = {2026},
  volume = {49},
  pages = {101513},
  doi = {10.1016/j.ctarc.2026.101513}
}
Kostenlos starten →